The Green Brief



    Lead Story
    Federal Rescheduling Era Begins: States and Industry Brace for New Reality
    With federal rescheduling of cannabis to Schedule III now in effect, state officials, regulators, and industry stakeholders are actively assessing the practical implications for medical marijuana programs across the country. A new analysis warns that rescheduling may inadvertently reward a cannabis supply chain built on fraudulent safety testing, raising serious compliance and consumer-safety concerns as federal oversight frameworks come online. Meanwhile, the Rockefeller Institute of Government released a sober assessment of rescheduling's limits, noting that core issues such as interstate commerce, banking access, and 280E tax liability remain unresolved at the federal level.
    Full analysis →

    

    Policy & Regulatory Watch
    
      State
      Kentucky Gov. Andy Beshear signed an executive order adding 15 new qualifying conditions to the state's medical cannabis program, significantly expanding patient access ahead of anticipated federal framework changes.
    
    
      State
      Illinois lawmakers advanced a cannabis reform bill targeting a licensing gap in the state's existing regulatory structure while also positioning the market for anticipated federal legalization developments.
    
    
      State
      New Jersey's legislature moved forward with changes to its marijuana law that could alter retail, licensing, and consumption regulations for consumers and operators statewide.
    

    

    Market Pulse
    
      
        MSOS
        $5.05
        -1.17%
      
      
        CURLF
        $3.59
        -1.27%
      
      
        TLRY
        $5.38
        -2.00%
      
      
        GTBIF
        $8.02
        -2.20%
      
      
        CRLBF
        $0.91
        -3.79%
      
      
        AYRWF
        $0.02
        -22.90%
      
    

    

    Quick Hits
    
      
      
        A new peer-reviewed analysis finds that opioid overdose deaths declined in states following the enactment of marijuana legalization laws, adding to the body of evidence cited by rescheduling advocates.
        Talking Joints Memo · 18h ago
      
    
    
      
      
        Aurora Cannabis deepened its veteran-support initiatives across Canada, expanding programs addressing food security, mental health, and community engagement as the company works to diversify its social-impact profile.
        PRNewswire · 20h ago
      
    
    
      
      
        Florida officials offered mixed reactions to federal medical marijuana rescheduling, reflecting ongoing uncertainty about how the state's large regulated market will interface with new federal oversight requirements.
        Florida Phoenix · 16h ago
      
    
    
      
      
        Cannabis equities broadly declined Wednesday, with AYRWF dropping nearly 23% and CRLBF falling close to 4%, as sector-wide selling pressure continued amid post-rescheduling regulatory uncertainty.
        Market Data · 1h ago
      
    

    

    From the Culture Desk
    
      
      
        After RFK: The Cannabis Festival Trail Still Has Three Big Stops Left
        The National Cannabis Festival pulled 25,000+ to RFK Stadium in April and may be the last one ever held there. The summer 2026 calendar has three stops that matter — a Midwest weekender in southern Ohio, a redwood-canopy gathering in Northern California that just became the first US festival with legal on-site sales, and a one-day civic anchor in Pittsburgh. A field guide.
        Read on cannanews.io →
        8 min read
      
    

    

    
      Seed & Stem — Today’s Context
      Terpenes are the aromatic hydrocarbons that give cannabis strains their distinctive smells and may modulate THC’s effects — a hypothesis known as the entourage effect. Myrcene (also found in mango and hops) is associated with sedating effects; limonene (citrus peel) with mood elevation. The clinical evidence is preliminary but commercially influential.
The Green Brief — Jun 3, 2026
